IL98881A - Esters of 2-amino-6-alkoxyl-9-(beta-d-arabinofuranosyl)-9h-purine derivatives their preparation and immunomodulating compositions containing them - Google Patents

Esters of 2-amino-6-alkoxyl-9-(beta-d-arabinofuranosyl)-9h-purine derivatives their preparation and immunomodulating compositions containing them

Info

Publication number
IL98881A
IL98881A IL9888191A IL9888191A IL98881A IL 98881 A IL98881 A IL 98881A IL 9888191 A IL9888191 A IL 9888191A IL 9888191 A IL9888191 A IL 9888191A IL 98881 A IL98881 A IL 98881A
Authority
IL
Israel
Prior art keywords
amino
purine
mmol
methoxy
arabinofuranosyl
Prior art date
Application number
IL9888191A
Other languages
English (en)
Other versions
IL98881A0 (en
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of IL98881A0 publication Critical patent/IL98881A0/xx
Publication of IL98881A publication Critical patent/IL98881A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Earth Drilling (AREA)
  • Stereophonic System (AREA)
  • Use Of Switch Circuits For Exchanges And Methods Of Control Of Multiplex Exchanges (AREA)
IL9888191A 1990-07-19 1991-07-18 Esters of 2-amino-6-alkoxyl-9-(beta-d-arabinofuranosyl)-9h-purine derivatives their preparation and immunomodulating compositions containing them IL98881A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909015914A GB9015914D0 (en) 1990-07-19 1990-07-19 Heterocyclic compounds

Publications (2)

Publication Number Publication Date
IL98881A0 IL98881A0 (en) 1992-07-15
IL98881A true IL98881A (en) 1996-01-19

Family

ID=10679359

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9888191A IL98881A (en) 1990-07-19 1991-07-18 Esters of 2-amino-6-alkoxyl-9-(beta-d-arabinofuranosyl)-9h-purine derivatives their preparation and immunomodulating compositions containing them

Country Status (23)

Country Link
US (3) US5492897A (pt)
EP (1) EP0539479B1 (pt)
JP (1) JP2873086B2 (pt)
KR (1) KR100187326B1 (pt)
AT (1) ATE151637T1 (pt)
CA (1) CA2087543C (pt)
CY (1) CY2165B1 (pt)
DE (1) DE69125715T2 (pt)
DK (1) DK0539479T3 (pt)
ES (1) ES2103311T3 (pt)
GB (1) GB9015914D0 (pt)
GR (1) GR3023776T3 (pt)
HU (2) HUT62911A (pt)
IE (1) IE912513A1 (pt)
IL (1) IL98881A (pt)
MC (1) MC2289A1 (pt)
MY (1) MY111871A (pt)
NZ (1) NZ239025A (pt)
PT (1) PT98371B (pt)
RU (1) RU2114860C1 (pt)
TW (1) TW208655B (pt)
WO (1) WO1992001456A1 (pt)
ZA (1) ZA915656B (pt)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9015914D0 (en) * 1990-07-19 1990-09-05 Wellcome Found Heterocyclic compounds
WO1998042352A1 (en) * 1997-03-24 1998-10-01 Glaxo Group Ltd. Method for treating b-cell tumors with ara-g nucleoside derivatives
ES2284256T3 (es) * 1998-07-02 2007-11-01 Kyowa Hakko Kogyo Co., Ltd. Medicamentos para la diabetes.
US6753322B2 (en) * 2000-06-06 2004-06-22 Pfizer Inc 2-aminocarbonyl-9H-purine derivatives
US7321033B2 (en) * 2001-11-27 2008-01-22 Anadys Pharmaceuticals, Inc. 3-B-D-ribofuranosylthiazolo [4,5-d] pyrimidine nucleosides and uses thereof
UA79764C2 (en) 2001-11-27 2007-07-25 Anadys Pharmaceuticals Inc 3-?-D-RIBOFURANOSYLTHIAZOLO[4,5-d]PYRIDIMINE NUCLEOSIDES AND USES THEREOF
US20040127435A1 (en) * 2002-08-02 2004-07-01 Regents Of The University Of California Uses for inhibitors of inosine monophosphate dehydrogenase
OA13310A (en) 2003-09-05 2007-04-13 Anadys Pharmaceuticals Inc TLR7 ligands for the treatment of hepatitis C.
GB0321613D0 (en) * 2003-09-15 2003-10-15 Drug Discovery Lab As Compounds
EP1804838A2 (en) * 2004-09-15 2007-07-11 Drug Discovery Laboratory AS Drug conjugates of long chain fatty acid or ester moieties as protein binding prodrugs
CA2596543A1 (en) * 2004-11-12 2006-05-18 Northwestern University Methods of treating hematological malignancies with nucleoside analog drugs
US7560544B2 (en) 2004-12-17 2009-07-14 Anadys Pharmaceuticals, Inc. 3,5-Disubsitituted and 3,5,7-trisubstituted-3H-oxazolo and 3H-thiazolo[4,5-d]pyrimidin-2-one compounds and prodrugs thereof
US20060189543A1 (en) * 2005-02-23 2006-08-24 Rosenbloom Richard A Compositions and methods for the treatment of leukemia
JP5117391B2 (ja) 2005-11-21 2013-01-16 アナディス ファーマシューティカルズ インク ５−アミノ−３Ｈ−チアゾロ［４，５−ｄ］ピリミジン−２−オンを調製するための新規な方法
EP2034834B1 (en) * 2006-06-22 2011-01-26 Anadys Pharmaceuticals, Inc. Prodrugs of 5-amino-3-(3'-deoxy-beta-d-ribofuranosyl)-thiazolo[4,5-d]pyrimidin-2,7-dione
DE602007012881D1 (en) 2006-07-18 2011-04-14 Anadys Pharmaceuticals Inc Carbonat- und carbamat-prodrugs von thiazolo ä4,5-dü-pyrimidinen
CN101768197A (zh) * 2008-12-29 2010-07-07 北京德众万全药物技术开发有限公司 一种奈拉滨的制备方法
EP2658857B1 (en) * 2010-12-29 2016-11-02 Inhibitex, Inc. Substituted purine nucleosides, phosphoroamidate and phosphorodiamidate derivatives for treatment of viral infections
WO2018230479A1 (ja) * 2017-06-13 2018-12-20 大原薬品工業株式会社 ヌクレオシド系抗がん剤又は抗ウィルス剤の５'位シリルエーテル誘導体
EP4267582A4 (en) * 2020-12-30 2024-06-05 Southern University of Science and Technology METHODS AND MODIFIED NUCLEOSIDES FOR THE TREATMENT OF CORONAVIRUS INFECTIONS

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2152486A1 (de) * 1970-11-20 1972-06-29 Akad Wissenschaften Ddr Verfahren zur Herstellung von 5'-Desoxy-5'-fluor-6-methyl-mercaptopurinribosid
US3872084A (en) * 1972-10-10 1975-03-18 Syntex Inc Purine nucleoside 3,5-cyclicphosphate compounds
US4081534A (en) * 1973-09-11 1978-03-28 Burroughs Wellcome Co. Amino purine nucleosides as autoimmune suppressant agents
GB1573777A (en) * 1977-11-03 1980-08-28 Wellcome Found 9-d-arabinonucleosides and an enzymatic process for their preparation
JPS61233696A (ja) * 1985-04-08 1986-10-17 Kanegafuchi Chem Ind Co Ltd ７−ヒドロキシグアニン誘導体及びその製造方法並びにそれを有効成分とする抗腫瘍剤
GB8712745D0 (en) * 1987-05-30 1987-07-01 Wellcome Found Antiviral compounds
CA1317291C (en) * 1987-12-14 1993-05-04 Naeem Botros Hanna Antitumor 6-sulfenamide, 6-sulfinamide and 6-sulfonamide purines, purine nucleosides, purine nucleotides and related compounds
US5352669A (en) * 1990-03-13 1994-10-04 The Of The United States Of America As Represented By The Department Of Health And Human Services O6 -benzylated guanine, guanosine and 2'-deoxyguanosine compounds possessing O6 -alkylguanine-DNA alkyltransferase depleting activity
GB9015914D0 (en) * 1990-07-19 1990-09-05 Wellcome Found Heterocyclic compounds

Also Published As

Publication number Publication date
PT98371A (pt) 1992-06-30
JPH05508649A (ja) 1993-12-02
JP2873086B2 (ja) 1999-03-24
EP0539479B1 (en) 1997-04-16
DE69125715D1 (de) 1997-05-22
TW208655B (pt) 1993-07-01
IL98881A0 (en) 1992-07-15
CA2087543A1 (en) 1992-01-20
GB9015914D0 (en) 1990-09-05
GR3023776T3 (en) 1997-09-30
MY111871A (en) 2001-02-28
CY2165B1 (en) 2002-08-23
EP0539479A1 (en) 1993-05-05
NZ239025A (en) 1993-08-26
IE912513A1 (en) 1992-01-29
DE69125715T2 (de) 1997-08-07
WO1992001456A1 (en) 1992-02-06
KR100187326B1 (ko) 1999-05-01
ZA915656B (en) 1993-03-31
ES2103311T3 (es) 1997-09-16
US5747472A (en) 1998-05-05
MC2289A1 (fr) 1993-07-14
AU641533B2 (en) 1993-09-23
US5492897A (en) 1996-02-20
PT98371B (pt) 1999-01-29
US5821236A (en) 1998-10-13
HU9300115D0 (en) 1993-04-28
RU2114860C1 (ru) 1998-07-10
ATE151637T1 (de) 1997-05-15
DK0539479T3 (da) 1997-08-25
HUT62911A (en) 1993-06-28
CA2087543C (en) 1998-08-25
AU8196091A (en) 1992-02-18

Similar Documents

Publication Publication Date Title
US5821236A (en) Tumor treatment with arabinofuranosyl purine derivatives
US5424295A (en) 9-β-D-arabinofuranasyl-2-amino-6-methaoxy-9H-purine
JP3933870B2 (ja) ２−（プリン−９−イル）−テトラヒドロフラン−３，４−ジオール誘導体
US5208241A (en) N-heteroaryl, n-alkylheteroaryl, n-alkenylheteroaryl and n-alkynylheteroarylmacrolides having immunosuppressive activity
US5032583A (en) 2,N-6-disubstituted adenosines and their antihypertensive methods of use
US5547941A (en) Cyclic dinucleoside diphosphorothioates, related compounds and pharmaceutical compositions
KR20010031875A (ko) 화학 화합물
JPH03209386A (ja) 免疫抑制活性を有するアミノマクロライドおよび誘導体
JPH09508144A (ja) 抗真菌ソルダリン誘導体
KR20180134835A (ko) 5-아자사이티딘류의 당 부분(糖部) 실릴에테르 유도체
JPH05501404A (ja) ヌクレオシド誘導体
EP0061283A1 (en) Antiviral agents, their preparation and use
EP0362967A1 (en) Nucleoside derivatives
AU641533C (en) Heterocyclic compounds
EP0104857A1 (en) Deoxyuridine compounds, methods for preparing them and their use in medicine
US4992534A (en) 3'-O-,5'-O-derivatives of 2'-deoxy-5-fluorouridine
EP0097039A1 (en) 5-(E-2-halovinyl)-2'-deoxyuridine derivatives, processes for their preparation, pharmaceutical compositions containing them, and their use in treating viral infections
EP0450102A1 (en) Nucleoside derivative
Byun et al. A short synthesis of antitumor ether thioglycolipids: Thioglycosidation of a glucose donor with a tributylstannyl sulfide acceptor
EP0319050B1 (en) Griseolic acid derivatives, their preparation and their use
JP3025541B2 (ja) ２−置換アデノシン誘導体および循環器疾患用薬
CN117603286A (zh) 一种溶酶体靶向的衰老细胞清除前药的制备及应用
US5585373A (en) 3-(7'-oxo-1'-aza-4'-oxabicyclo[3.2.0]-hept-3'-YL)propionic acid derivative as antitumor agent
EP0492430A1 (en) Oxetanocin derivative having imidazole base group
JPH09316093A (ja) ポリリン酸誘導体

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired